Where does Meditech Spine, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Meditech Spine, LLC ranks #22,965 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Meditech Spine, LLC hold?

Meditech Spine, LLC holds 12 US utility patents granted between 2016 and 2023, spanning 3 technology areas.

What is Meditech Spine, LLC's Innovation Score?

Meditech Spine, LLC has an Innovation Score of 31.0 out of 100 (36th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Meditech Spine, LLC focus on?

Meditech Spine, LLC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 8 patents, ranking #2,086 of 7,127 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Meditech Spine, LLC's patent grant rate increasing or decreasing?

Meditech Spine, LLC's recent grant velocity is -29% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Meditech Spine, LLC's patents?

Meditech Spine, LLC's patents average 18.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Meditech Spine, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Meditech Spine, LLC

USPTO PatentsView assignee record - 12 granted patents across 3 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Meditech ranks #22,965 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 3 technology areas.

#22,965
of 49,997 US assignees by volume: 36th percentile
by Innovation Score (31.0/100): 18.4
avg claims per patent: -29%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22965 · US Corporation #22,965 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,965/49,997
PHOTO-FINISH Mechanical Dynamics…
CPC-NARROW A61B · 3 areas
INNOV-THIN 31.0/100
CLAIMS-RICH 18.4 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -29% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mechanical Dynamics and Analysis LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Meditech’s 31.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (29%) Velocity 5.0 pts (16%) Breadth 6.1 pts (20%) Claim depth 11.1 pts (36%)

Qualcomm Incorporated · highest

85
Meditech Spine · this assignee

31
3D Lighting… · lowest

7

What this shows Meditech's Innovation Score is 31.0/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Meditech?

Each dot is one of Meditech’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Meditech’s own 18.4 claims/patent is ABOVE the 10.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Meditech vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Meditech's grants concentrate

Meditech Spine, LLC is a focused PatentsView assignee: 3 CPC subclasses with 66.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2016. By volume, Meditech sits between Mechanical Dynamics and Analysis LLC and Memorial University of Newfoundland.

Meditech's three-year grant acceleration

Meditech Spine, LLC shows 3 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mechanical Dynami…

12
Medea

12
Medical informati…

12
Medikine

12
Megakaryon

12
Meizu Technology

12
Melior Pharmaceut…

12
Memorial Universi…

12
Meditech Spine ◀

12

What this shows Meditech holds 12 patents at rank #22,993, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Meditech

By rank, the assignees closest to #22,993 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Meditech's primary technology class.

Meditech's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Meditech Spine, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	8.3%
2017	3	25.0%
2018	1	8.3%
2019	2	16.7%
2020	2	16.7%
2022	2	16.7%
2023	1	8.3%

Which technologies does Meditech Spine, LLC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 8

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 7

H10D - Inorganic Electric Semiconductor Devices 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Meditech Spine, LLC's patent record in context - here's where to go next.

Meditech Spine, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 66.7% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #22,965 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Meditech Spine, LLC against Mechanical Dynamics and Analysis LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.